 | • レポートコード：GIR-22F19262 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Diabetic Therapeutic Drugs Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の糖尿病治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 糖尿病治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・インスリン療法、非インスリン療法 アプリケーション別セグメントは次のように区分されます。 ・1型糖尿病、2型糖尿病、妊娠糖尿病 世界の糖尿病治療薬市場の主要な市場プレーヤーは以下のとおりです。 ・AstraZeneca、Eli Lilly、Merck、Novo Nordisk、Sanofi、Pfizer、Novartis、Perle Biosciences、Sun Pharma、Takeda Pharmaceuticals、F. Hoffmann-La Roche、Belrose Pharma、Mitsubishi Tanabe Pharma、Dong-A ST、Eisai、Arbutus Biopharma 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、糖尿病治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な糖尿病治療薬メーカーの企業概要、2019年～2022年までの糖尿病治療薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な糖尿病治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別糖尿病治療薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの糖尿病治療薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での糖尿病治療薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および糖尿病治療薬の産業チェーンを掲載しています。 ・第13、14、15章では、糖尿病治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 糖尿病治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：インスリン療法、非インスリン療法 - アプリケーション別分析（2017年vs2021年vs2028年）：1型糖尿病、2型糖尿病、妊娠糖尿病 - 世界の糖尿病治療薬市場規模・予測 - 世界の糖尿病治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AstraZeneca、Eli Lilly、Merck、Novo Nordisk、Sanofi、Pfizer、Novartis、Perle Biosciences、Sun Pharma、Takeda Pharmaceuticals、F. Hoffmann-La Roche、Belrose Pharma、Mitsubishi Tanabe Pharma、Dong-A ST、Eisai、Arbutus Biopharma ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：インスリン療法、非インスリン療法 ・アプリケーション別分析2017年-2028年：1型糖尿病、2型糖尿病、妊娠糖尿病 ・糖尿病治療薬の北米市場分析 - 糖尿病治療薬の北米市場：タイプ別市場規模2017年-2028年 - 糖尿病治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・糖尿病治療薬のヨーロッパ市場分析 - ：糖尿病治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：糖尿病治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・糖尿病治療薬のアジア太平洋市場分析 - 糖尿病治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 糖尿病治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・糖尿病治療薬の南米市場分析 - 糖尿病治療薬の南米市場：タイプ別市場規模2017年-2028年 - 糖尿病治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・糖尿病治療薬の中東・アフリカ市場分析 - 糖尿病治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 糖尿病治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Diabetic Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Diabetic Therapeutic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Type 1 Diabetes accounting for % of the Diabetic Therapeutic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Insulin Therapies segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Diabetic Therapeutic Drugs include AstraZeneca, Eli Lilly, Merck, Novo Nordisk, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Diabetic Therapeutic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin Therapies
Non-Insulin Therapies
Market segment by Application can be divided into
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
The key market players for global Diabetic Therapeutic Drugs market are listed below:
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Pfizer
Novartis
Perle Biosciences
Sun Pharma
Takeda Pharmaceuticals
F. Hoffmann-La Roche
Belrose Pharma
Mitsubishi Tanabe Pharma
Dong-A ST
Eisai
Arbutus Biopharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diabetic Therapeutic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diabetic Therapeutic Drugs, with price, sales, revenue and global market share of Diabetic Therapeutic Drugs from 2019 to 2022.
Chapter 3, the Diabetic Therapeutic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diabetic Therapeutic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Diabetic Therapeutic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetic Therapeutic Drugs.
Chapter 13, 14, and 15, to describe Diabetic Therapeutic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Diabetic Therapeutic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diabetic Therapeutic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Insulin Therapies
1.2.3 Non-Insulin Therapies
1.3 Market Analysis by Application
1.3.1 Overview: Global Diabetic Therapeutic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes
1.4 Global Diabetic Therapeutic Drugs Market Size & Forecast
1.4.1 Global Diabetic Therapeutic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Diabetic Therapeutic Drugs Sales in Volume (2017-2028)
1.4.3 Global Diabetic Therapeutic Drugs Price (2017-2028)
1.5 Global Diabetic Therapeutic Drugs Production Capacity Analysis
1.5.1 Global Diabetic Therapeutic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Diabetic Therapeutic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetic Therapeutic Drugs Market Drivers
1.6.2 Diabetic Therapeutic Drugs Market Restraints
1.6.3 Diabetic Therapeutic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Diabetic Therapeutic Drugs Product and Services
2.1.4 AstraZeneca Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Diabetic Therapeutic Drugs Product and Services
2.2.4 Eli Lilly Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Diabetic Therapeutic Drugs Product and Services
2.3.4 Merck Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Diabetic Therapeutic Drugs Product and Services
2.4.4 Novo Nordisk Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Diabetic Therapeutic Drugs Product and Services
2.5.4 Sanofi Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Diabetic Therapeutic Drugs Product and Services
2.6.4 Pfizer Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Diabetic Therapeutic Drugs Product and Services
2.7.4 Novartis Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Perle Biosciences
2.8.1 Perle Biosciences Details
2.8.2 Perle Biosciences Major Business
2.8.3 Perle Biosciences Diabetic Therapeutic Drugs Product and Services
2.8.4 Perle Biosciences Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Diabetic Therapeutic Drugs Product and Services
2.9.4 Sun Pharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Takeda Pharmaceuticals
2.10.1 Takeda Pharmaceuticals Details
2.10.2 Takeda Pharmaceuticals Major Business
2.10.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product and Services
2.10.4 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 F. Hoffmann-La Roche
2.11.1 F. Hoffmann-La Roche Details
2.11.2 F. Hoffmann-La Roche Major Business
2.11.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Product and Services
2.11.4 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Belrose Pharma
2.12.1 Belrose Pharma Details
2.12.2 Belrose Pharma Major Business
2.12.3 Belrose Pharma Diabetic Therapeutic Drugs Product and Services
2.12.4 Belrose Pharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Mitsubishi Tanabe Pharma
2.13.1 Mitsubishi Tanabe Pharma Details
2.13.2 Mitsubishi Tanabe Pharma Major Business
2.13.3 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product and Services
2.13.4 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Dong-A ST
2.14.1 Dong-A ST Details
2.14.2 Dong-A ST Major Business
2.14.3 Dong-A ST Diabetic Therapeutic Drugs Product and Services
2.14.4 Dong-A ST Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Eisai
2.15.1 Eisai Details
2.15.2 Eisai Major Business
2.15.3 Eisai Diabetic Therapeutic Drugs Product and Services
2.15.4 Eisai Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Arbutus Biopharma
2.16.1 Arbutus Biopharma Details
2.16.2 Arbutus Biopharma Major Business
2.16.3 Arbutus Biopharma Diabetic Therapeutic Drugs Product and Services
2.16.4 Arbutus Biopharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Diabetic Therapeutic Drugs Breakdown Data by Manufacturer
3.1 Global Diabetic Therapeutic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Diabetic Therapeutic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Diabetic Therapeutic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Diabetic Therapeutic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Diabetic Therapeutic Drugs Manufacturer Market Share in 2021
3.5 Global Diabetic Therapeutic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Diabetic Therapeutic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diabetic Therapeutic Drugs Market Size by Region
4.1.1 Global Diabetic Therapeutic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Diabetic Therapeutic Drugs Revenue by Region (2017-2028)
4.2 North America Diabetic Therapeutic Drugs Revenue (2017-2028)
4.3 Europe Diabetic Therapeutic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Diabetic Therapeutic Drugs Revenue (2017-2028)
4.5 South America Diabetic Therapeutic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Diabetic Therapeutic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Diabetic Therapeutic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Diabetic Therapeutic Drugs Revenue by Type (2017-2028)
5.3 Global Diabetic Therapeutic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Diabetic Therapeutic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Diabetic Therapeutic Drugs Revenue by Application (2017-2028)
6.3 Global Diabetic Therapeutic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Diabetic Therapeutic Drugs Sales by Type (2017-2028)
7.2 North America Diabetic Therapeutic Drugs Sales by Application (2017-2028)
7.3 North America Diabetic Therapeutic Drugs Market Size by Country
7.3.1 North America Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Diabetic Therapeutic Drugs Sales by Type (2017-2028)
8.2 Europe Diabetic Therapeutic Drugs Sales by Application (2017-2028)
8.3 Europe Diabetic Therapeutic Drugs Market Size by Country
8.3.1 Europe Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Diabetic Therapeutic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Diabetic Therapeutic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Diabetic Therapeutic Drugs Market Size by Region
9.3.1 Asia-Pacific Diabetic Therapeutic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Diabetic Therapeutic Drugs Sales by Type (2017-2028)
10.2 South America Diabetic Therapeutic Drugs Sales by Application (2017-2028)
10.3 South America Diabetic Therapeutic Drugs Market Size by Country
10.3.1 South America Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diabetic Therapeutic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Diabetic Therapeutic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Diabetic Therapeutic Drugs Market Size by Country
11.3.1 Middle East & Africa Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Diabetic Therapeutic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Diabetic Therapeutic Drugs
12.3 Diabetic Therapeutic Drugs Production Process
12.4 Diabetic Therapeutic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Diabetic Therapeutic Drugs Typical Distributors
13.3 Diabetic Therapeutic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer